EE53 A Cost of Illness Analysis of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) With FLT3 Mutations in Chile: A Public Payer Perspective
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.354
https://www.valueinhealthjournal.com/article/S1098-3015(24)00469-8/fulltext
Title :
EE53 A Cost of Illness Analysis of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) With FLT3 Mutations in Chile: A Public Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00469-8&doi=10.1016/j.jval.2024.03.354
First page :
Section Title :
Open access? :
No
Section Order :
11696